RxDoctor Payments Data

George Lawson, MD

Plastic Surgery · Winston Salem, NCNPI 1225185010

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,599 of the $5,279 with a category attached, or 68.2%. AbbVie accounts for 64.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $2,489 and has fallen 72.1% since, to $695 in 2025.

$5,279in general payments, 2019–2025

Across 131 payments — averaging $40.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Mentor Worldwide LLC$390
  • Sientra, Inc.$380
  • Smith+Nephew$167
  • Osiris Therapeutics Inc.$110
  • Pacira Pharmaceuticals Incorporated$106
  • plus $743 from 16 others
$12,043in research payments, 2019–2025

Across 14 payments — averaging $860.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$9K
  • Medical Device Business Services, Inc.$3K

What the payments were for

  • Speaking & faculty fees$1,68032%
  • Food & beverage$3,59968%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,279 in reported general payments places this provider in the 65th percentile of 128 plastic surgery providers in North Carolina.

See all plastic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,950
Medicare patients
49
Services billed
132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl40$202
Cephalexin31$167
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$139
Baclofen16$50

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →